← All stories
Markets
How Is AstraZeneca (LSE:AZN) Steering The UK Healthcare Story As NHS Access Widens?
Highlights NICE backing widens NHS access to AstraZeneca acalabrutinib-based combinations in England and Wales Haematology franchise offers a visible counterweight to earlier late-stage trial disappointment Healthcare has been an uneven par…
Covered by 1 outlet
All coverage · 1 article